1. Home
  2. RUN vs IDYA Comparison

RUN vs IDYA Comparison

Compare RUN & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrun Inc.

RUN

Sunrun Inc.

HOLD

Current Price

$12.47

Market Cap

3.1B

Sector

Miscellaneous

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$31.67

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RUN
IDYA
Founded
2007
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.9B
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
RUN
IDYA
Price
$12.47
$31.67
Analyst Decision
Buy
Strong Buy
Analyst Count
20
16
Target Price
$18.80
$52.86
AVG Volume (30 Days)
7.6M
1.5M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
113.35
61.90
EPS
1.71
N/A
Revenue
$858,578,000.00
$218,710,000.00
Revenue This Year
$2.81
N/A
Revenue Next Year
$4.54
$201.05
P/E Ratio
$6.87
N/A
Revenue Growth
12.97
3024.43
52 Week Low
$5.38
$16.82
52 Week High
$22.44
$39.28

Technical Indicators

Market Signals
Indicator
RUN
IDYA
Relative Strength Index (RSI) 44.75 46.80
Support Level $12.01 $29.51
Resistance Level $13.57 $34.76
Average True Range (ATR) 0.69 2.02
MACD 0.01 0.09
Stochastic Oscillator 24.75 18.94

Price Performance

Historical Comparison
RUN
IDYA

About RUN Sunrun Inc.

Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: